Libre, Lance T.

HRN: 20-91-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/05/2022
12/11/2022
IVT
175mg
Q6hrs
Urti; Age With Mod DHn
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: